Intel reported better-than-anticipated first quarter earnings and positive Q2 outlook on Thursday, sending shares soaring as ...
Edwards Lifesciences today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook Q1 sales grew 16.7% to $1.65 billion1, constant currency2 sales grew 12.7% Q1 TAVR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results